Active Funding Opportunities and Notices for NICHD
NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.
NOTs and Active NOFOs for NICHD
Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.
Number | Exp. Date | Activity Code(s) | Title Sort ascending |
---|---|---|---|
NOT-HD-09-004 | January 1, 2027 | Withdrawal Notice: NICHD RFA-HD-08-021, Pediatric Pharmacology and Therapeutics Research Consortium (PPTRC) (U54) | |
NOT-HD-02-003 | January 1, 2027 | VIOLENCE PREVENTION AMONG HIGH-RISK EARLY ADOLESCENT YOUTH | |
RFA-HD-25-009 | July 25, 2024 | R21 | Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 - Clinical Trial Not Allowed) |
NOT-HD-11-020 | January 1, 2027 | Updates to Section IV, specialized Program Information RFA-OD-11-002 Building Interdisciplinary Research Careers in Womens Health (K12) |
|
NOT-HD-05-008 | January 1, 2027 | Updated Information and Clarification: RFA-HD-05-018 Pediatric HIV/AIDS Cohort Study (PHACS) | |
NOT-HD-05-009 | January 1, 2027 | Updated Information and Clarification: RFA-HD-04-025 - Adolescent Medicine Trials Network for HIV/AIDS Interventions | |
NOT-HD-16-010 | January 1, 2027 | Updated Application Forms (FORMS-D) Available for PAR-16-106 "Rapid Assessment of Zika Virus (ZIKV) Complications (R21)" on May 25, 2016 | |
PAR-24-059 | January 8, 2027 | R01 | Understanding the Impact of Healthcare System and Clinician Factors on Disparities in Maternal Morbidity and Mortality (R01 - Clinical Trial Optional) |
RFA-OD-23-013 | June 21, 2024 | R21 | Understanding Chronic Conditions Understudied Among Women (R21 Clinical Trial Optional) |
RFA-OD-23-014 | June 21, 2024 | R01 | Understanding Chronic Conditions Understudied Among Women (R01 Clinical Trial Optional) |
PAR-23-131 | May 8, 2026 | R21 | Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) |
PAR-23-130 | May 8, 2026 | R01 | Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional) |
RFA-OD-22-009 | July 2, 2024 | R01 | Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed) |
PAR-22-233 | March 2, 2025 | R61/R33 | Time-Sensitive Opportunities for Health Research (R61/R33 Clinical Trial Not Allowed) |
PAR-21-305 | January 10, 2025 | R01 | Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed) |
NOT-HD-07-013 | January 1, 2027 | The National Standard for Normal Fetal Growth | |
NOT-HD-05-013 | January 1, 2027 | The National Institute of Child Health and Human Development Consortium on Safe Labor | |
NOT-HD-08-006 | January 1, 2027 | The National Children's Study NCS Environmental Sample Analytical Laboratories | |
NOT-HD-09-013 | January 1, 2027 | The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) will not participate in NOT-OD-09-058 NIH Announces the Availability of Recovery Act Funds for Competitive Revision Applications | |
NOT-HD-12-035 | January 1, 2027 | The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Announces the Creation of Two New Branches to Better Facilitate NICHD Research Priorities |